|Articles|December 10, 2011
Video blog: HER2-targeted agents
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
4
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
5